Two more COVID-19 vaccines granted conditional usage approval in China
Updated 2021.02.25 20:44 GMT+8
CGTN
China's National Medical Products Administration (NMPA) on Thursday granted conditional usage approval to two COVID-19 vaccines developed by Sinopharm and CanSinoBIO.